PET/CT

Positron emission tomography/computed tomography is a hybrid nuclear medicine imaging technique that helps radiologists spot abnormal metabolic activity. PET/CT is commonly used to diagnose cancers, heart diseases and certain brain disorders, among other conditions.

Telix says new kidney cancer imaging agent alters treatment plans for 50% of patients
The positive findings come after the U.S. Food and Drug Administration previously shared concerns related to sterility assurance issues during the drug’s production.
UCLA launches ‘first of its kind’ new standalone Department of Nuclear Medicine and Theranostics
“Becoming an independent department elevates this work and strengthens UCLA’s role in shaping the future of precision health," said the department's new acting chairman.
Largest network of private cardiology groups in US to deploy GE HealthCare's cardiac PET tracer
One of the tracer’s more significant advantages is its extended half-life of 109 minutes—significantly longer than other currently available PET MPI imaging agents.
Some PET exams may be overutilized in oncology
In 2020 alone, there were more than 2 million 18F-FDG PET/CT scans conducted in the United States.
PSMA-PET imaging not the most cost-effective option for many prostate cancer patients
The exam effectively helps providers manage patients’ treatment options, but for some, the costs associated with those treatments may negate the value of its findings.

COVID remnants still show up on PET/CT scans years after infection

That’s according to new PET imaging that shows the presence of activated T cells in the brain, spinal cord, gut and lung tissues of individuals who have recovered from COVID.

Frequent sleep disruptions may increase amyloid deposits down the road

Daily sleep disruptions could increase the risk of developing Alzheimer’s disease in the future, new research suggests.

Hearing aids help slow brain aging in individuals with mild cognitive impairment

Hearing aids help stall brain aging, new imaging study shows

For people with auditory impairment, hearing aid use could slow metabolic decline in regions of the brain associated with cognitive function.

stroke brain dementia alzheimer's puzzle mental health

Friends and family noticing differences in loved ones' memory could predict early changes in the brain

Experts recently uncovered strong associations between reports of memory loss from patients' peers/loved ones and the presence of tau tangles on imaging.

New Drug Application for PSMA-PET 'cold kit' could expand access to prostate imaging

If approved, the kit could allow for more flexible production of prostate cancer imaging agents.

alzheimer's disease dementia brain imaging

Machine learning winnows memory-care cohort to only the most appropriate nuc-med patients

An AI-aided way has emerged to confidently select dementia patients who are likely to benefit from amyloid-PET imaging while appropriately de-selecting patients for whom the costly exam would probably be unhelpful.

medical imaging carbon emissions climate change

PET is an energy hog, but relatively rare utilization lessens its carbon footprint. MRI and CT have no such ‘out’

Medical imaging machinery uses a lot of power, and the extent to which it quickens the pace of global warming is becoming clearer.

Researchers identify new PET imaging biomarker capable of predicting immunotherapy success

A newly identified PET imaging biomarker could help providers tailor immunotherapy treatments for patients with certain types of cancers.

PET/CT

Telix says new kidney cancer imaging agent alters treatment plans for 50% of patients

UCLA launches ‘first of its kind’ new standalone Department of Nuclear Medicine and Theranostics

Largest network of private cardiology groups in US to deploy GE HealthCare's cardiac PET tracer

Some PET exams may be overutilized in oncology

PSMA-PET imaging not the most cost-effective option for many prostate cancer patients